硕世生物
(688399)
| 流通市值：43.05亿 | | | 总市值：43.05亿 |
| 流通股本：5862.00万 | | | 总股本：5862.00万 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 91,119,399.55 | 403,179,297.92 | 276,432,339.01 | 186,614,720.28 |
| 营业收入 | 91,119,399.55 | 403,179,297.92 | 276,432,339.01 | 186,614,720.28 |
| 二、营业总成本 | 88,153,703.32 | 618,868,942.98 | 437,980,740.76 | 261,290,297.53 |
| 营业成本 | 26,490,695.75 | 145,498,166.18 | 110,227,601.35 | 65,805,143.93 |
| 税金及附加 | 1,772,505.8 | 8,052,251.81 | 5,030,622.52 | 3,415,621.38 |
| 销售费用 | 28,549,156.64 | 200,232,962.7 | 141,973,467.48 | 88,671,475.5 |
| 管理费用 | 16,203,846.73 | 177,249,414.66 | 105,991,024.52 | 47,911,342.17 |
| 研发费用 | 19,762,499.26 | 135,532,978.11 | 98,908,502.56 | 68,766,946.68 |
| 财务费用 | -4,625,000.86 | -47,696,830.48 | -24,150,477.67 | -13,280,232.13 |
| 其中:利息费用 | 1,834,800.55 | 6,938,959.58 | 5,672,367.43 | 3,555,960.11 |
| 其中:利息收入 | 6,418,418.02 | 55,970,553.82 | 29,923,661.23 | 15,267,870.45 |
| 加:公允价值变动收益 | 3,176,155.66 | 13,116,997.99 | 7,500,948.92 | 4,534,682.73 |
| 加:投资收益 | -846,408.12 | 1,584,859.96 | -1,650,692.44 | -1,303,979.9 |
| 资产处置收益 | 886,454.11 | 3,884,684.32 | 2,654,077.23 | 1,259,452.46 |
| 资产减值损失(新) | 236,443.26 | -187,445,504.38 | -37,965,182.68 | -20,721,849.58 |
| 信用减值损失(新) | 3,007,631.6 | -29,396,687.08 | -3,197,629.14 | -4,489,717.54 |
| 其他收益 | 30,716,671.24 | 48,888,260.7 | 32,571,514.81 | 27,966,299.01 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 40,142,643.98 | -365,057,033.55 | -161,635,365.05 | -67,430,690.07 |
| 加:营业外收入 | 23,187.82 | 1,205,396.97 | 1,124,975.08 | 1,067,875.83 |
| 减:营业外支出 | 2,228.02 | 11,818,539.92 | 3,791,638.86 | 1,684,619.71 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 40,163,603.78 | -375,670,176.5 | -164,302,028.83 | -68,047,433.95 |
| 减:所得税费用 | 95,645.77 | -1,858,821.77 | 11,712,272.62 | 247,231.11 |
| 六、净利润 | 40,067,958.01 | -373,811,354.73 | -176,014,301.45 | -68,294,665.06 |
| 持续经营净利润 | 40,067,958.01 | -373,811,354.73 | -176,014,301.45 | -68,294,665.06 |
| 归属于母公司股东的净利润 | 40,067,958.01 | -373,811,354.73 | -176,014,301.45 | -68,294,665.06 |
| (一)基本每股收益 | 0.68 | -6.38 | -3 | -1.17 |
| (二)稀释每股收益 | 0.68 | -6.38 | -3 | -1.17 |
| 九、综合收益总额 | 40,067,958.01 | -373,811,354.73 | -176,014,301.45 | -68,294,665.06 |
| 归属于母公司股东的综合收益总额 | 40,067,958.01 | -373,811,354.73 | -176,014,301.45 | -68,294,665.06 |
| 公告日期 | 2024-04-27 | 2024-04-27 | 2023-10-28 | 2023-08-31 |
| 审计意见(境内) | | 标准无保留意见 | | |